These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Combined intrathecal and intramuscular gentamicin for gram-negative meningitis. Pharmacologic study of 21 patients. Rahal JJ; Hyams PJ; Simberkoff MS; Rubinstein E N Engl J Med; 1974 Jun; 290(25):1394-8. PubMed ID: 4208369 [No Abstract] [Full Text] [Related]
23. Bacterial meningitis in children: diagnosis and therapy. A review of recent developments. Stutman HR; Marks MI Clin Pediatr (Phila); 1987 Sep; 26(9):431-8. PubMed ID: 3304773 [No Abstract] [Full Text] [Related]
24. Pharmacodynamics of antibiotics in the therapy of meningitis: infection model observations. Schmidt T; Täuber MG J Antimicrob Chemother; 1993 May; 31 Suppl D():61-70. PubMed ID: 8335525 [TBL] [Abstract][Full Text] [Related]
25. [Penetration of antibiotics into the cerebrospinal fluid. Theoretical and practical aspects (author's transl)]. Modai J Nouv Presse Med; 1980 Dec; 9(47):3615-20. PubMed ID: 6937071 [TBL] [Abstract][Full Text] [Related]
26. Designing appropriate therapy in the treatment of gram-negative bacillary meningitis. Corrado ML; Gombert ME; Cherubin CE JAMA; 1982 Jul; 248(1):71-4. PubMed ID: 7087095 [TBL] [Abstract][Full Text] [Related]
27. How we handle meningitis. Gongaware T; Garvey G Med Times; 1976 Jan; 104(1):91-2. PubMed ID: 1246176 [No Abstract] [Full Text] [Related]
28. [Significance of monomycin concentration in the cerebrospinal fluid in the treatment of experimental purulent meningitis]. Mosiĭchuk NM Zh Eksp Klin Med; 1969; 9(5):47-51. PubMed ID: 4913233 [No Abstract] [Full Text] [Related]
29. [Permeability of the hemato-encephalic barrier to antibiotics in patients with infectious meningitis]. Mosiĭchuk NM Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(3):338-42. PubMed ID: 4872691 [No Abstract] [Full Text] [Related]
30. Antibiotic susceptibility of 629 bacterial blood and CSF isolates from Swedish infants and the therapeutic implications. Tullus K; Olsson-Liljequist B; Lundström G; Burman LG Acta Paediatr Scand; 1991 Feb; 80(2):205-12. PubMed ID: 2035312 [TBL] [Abstract][Full Text] [Related]
31. The influence of dosing schedules and cerebrospinal fluid bactericidal activity on the therapy of bacterial meningitis. Scheld WM; Tauber MG; Zak O; Sande MA J Antimicrob Chemother; 1985 Jan; 15 Suppl A():303-12. PubMed ID: 3980333 [TBL] [Abstract][Full Text] [Related]
32. Current concepts of bacterial infections of the central nervous system. Bacterial meningitis and bacterial brain abscess. Garvey G J Neurosurg; 1983 Nov; 59(5):735-44. PubMed ID: 6352873 [TBL] [Abstract][Full Text] [Related]
33. Antibiotic therapy of bacterial meningitis: lessons we've learned. Sande MA Am J Med; 1981 Oct; 71(4):507-10. PubMed ID: 7282738 [No Abstract] [Full Text] [Related]
35. Developing or normocellular bacterial meningitis. Fimlt AM; Hamilton W N Z Med J; 1976 Jul; 84(567):6-8. PubMed ID: 1067504 [TBL] [Abstract][Full Text] [Related]
36. Assessment of antibiotic efficacy in acute bacterial meningitis. Beam TR; Allen JC Clin Pharmacol Ther; 1979 Feb; 25(2):199-203. PubMed ID: 759073 [TBL] [Abstract][Full Text] [Related]
37. Modification of laboratory results by partial treatment of bacterial meningitis. Dalton HP; Allison MJ Am J Clin Pathol; 1968 Mar; 49(3):410-3. PubMed ID: 4384575 [No Abstract] [Full Text] [Related]
39. Inhibition of nitric oxide synthase partially attenuates alterations in the blood-cerebrospinal fluid barrier during experimental meningitis in the rat. Boje KM Eur J Pharmacol; 1995 Jan; 272(2-3):297-300. PubMed ID: 7536164 [TBL] [Abstract][Full Text] [Related]